PIK3CA and head and neck squamous cell carcinoma: Treatment of HNSCC cell lines with IQ3 peptide, suppressed PI3K signaling, and inhibited cell survival, proliferation, migration and invasion, indicating that IQGAP1-mediated PI3K signaling is critical for human HNSCC cells [19, 22].